Pages that link to "Q37902966"

The following pages link to Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer (Q37902966):

Displaying 42 items.

• Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions (Q22305604) (← links)
• Broad targeting of angiogenesis for cancer prevention and therapy (Q27002903) (← links)
• The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system (Q27024460) (← links)
• Artificial light at night: melatonin as a mediator between the environment and epigenome (Q28085136) (← links)
• Circadian rhythms in liver metabolism and disease (Q28392853) (← links)
• The cellular state determines the effect of melatonin on the survival of mixed cerebellar cell culture (Q28542743) (← links)
• Melatonin, an inhibitory agent in breast cancer. (Q30489143) (← links)
• Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway (Q31172625) (← links)
• Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis (Q33624824) (← links)
• Regulated DNA methylation and the circadian clock: implications in cancer (Q34318008) (← links)
• Melatonin anticancer effects: review (Q34647628) (← links)
• Expression of the MT1 melatonin receptor in ovarian cancer cells (Q34835245) (← links)
• Individual variations in serum melatonin levels through time: implications for epidemiologic studies. (Q35077971) (← links)
• Melatonin: an inhibitor of breast cancer (Q35689110) (← links)
• Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal (Q35815736) (← links)
• A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats (Q35867113) (← links)
• Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1 G protein‐coupled receptor via repression of ERα, Akt1, and Stat5 (Q36174451) (← links)
• Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin (Q36251714) (← links)
• Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival (Q36554668) (← links)
• Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells (Q36904849) (← links)
• Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer (Q37458674) (← links)
• The effects of shift work on physical and mental health (Q38001339) (← links)
• Molecular mechanisms of melatonin's inhibitory actions on breast cancers. (Q38046127) (← links)
• Circadian clock disruptions and the risk of cancer (Q38052599) (← links)
• Expression and putative functions of melatonin receptors in malignant cells and tissues (Q38229317) (← links)
• The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis (Q38973727) (← links)
• A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations (Q39189852) (← links)
• Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma (Q39208543) (← links)
• Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling (Q39393886) (← links)
• Simultaneous modulation of COX‐2, p300, Akt, and Apaf‐1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells (Q39396408) (← links)
• Melatonin receptors: molecular pharmacology and signaling in the context of system bias. (Q39434518) (← links)
• Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study (Q48200182) (← links)
• Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma (Q50956679) (← links)
• Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study (Q51789923) (← links)
• Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells. (Q55262346) (← links)
• Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction (Q58753365) (← links)
• Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction (Q58914961) (← links)
• The Effect of Light Exposure at Night (LAN) on Carcinogenesis via Decreased Nocturnal Melatonin Synthesis (Q59210075) (← links)
• Artificial Light at Night of Different Spectral Compositions Differentially Affects Tumor Growth in Mice: Interaction With Melatonin and Epigenetic Pathways (Q59808521) (← links)
• Circadian protein CLK suppresses transforming growth factor-β expression in peripheral B cells of nurses with day-night shift rotation (Q60953224) (← links)
• Stimulatory Effect of Indolic Hormone on As2O3 Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin (Q90358672) (← links)
• Melatonin: Countering Chaotic Time Cues (Q92404206) (← links)